biotech
Swiss biotech firm faces big bill after US lawsuit
<p>Swiss biotech group Actellion has been told by a US court that it will have to pay a Japanese company up to $547 million over a cancelled contract.</p>
<p>Swiss biotech group Actellion has been told by a US court that it will have to pay a Japanese company up to $547 million over a cancelled contract.</p>